Despite significant advancements in our understanding of the immunogenetics underlying ITP, there remains a paucity of data on the prevalence and clinical impact of these FCGR polymorphisms in specific populations especially among children in the Arab world (8). This evidence concerns the gene FCGR2A and autoimmune thrombocytopenic purpura.